Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Mirum Pharmaceuticals Inc’s current trading price is -6.45% away from its 52-week high, while its distance from the 52-week low is 116.25%. The stock’s price range over this period has fluctuated between $23.14 and $53.49. The company, operating within the financial sector, had a trading volume of approximately 0.4 million for the day, which was noticeably lower than the average daily share volume of 0.45 million over the last 3 months.
The market performance of Mirum Pharmaceuticals Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $53.49 on 02/05/25, while the lowest value for the same duration was $23.14 on 04/25/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Mirum Pharmaceuticals Inc (MIRM) has experienced a quarterly rise of 18.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.40B and boasts a workforce of 264 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 43.19, with a change in price of +11.08. Similarly, Mirum Pharmaceuticals Inc recorded 405,053 in trading volume during the last 100 days, posting a change of +28.44%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MIRM stands at 1.37. Similarly, the long-term debt-to-equity ratio is also 1.36.
MIRM Stock Stochastic Average
Today’s raw stochastic average for Mirum Pharmaceuticals Inc over the last 50 days is 74.37%.This indicates a increase from the raw stochastic average of the past 20 days, which was 58.08%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 64.85% and 68.10%, respectively.
MIRM Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 21.02%. However, over the last six months, the performance has been weaker by 20.61%. The price of MIRM increased 8.01% over the last 30 days. And in the last five days, it has fallen by -2.00%.
